January 2024 MHRA Safety Communications Summary
The MHRA has published a summary of letters and notifications issued to healthcare professionals during January 2024 concerning medicines and medical devices. This update consolidates important safety information relevant to prescribers, dispensers, and clinical teams across all settings.
What You Need to Know
The January 2024 communications package includes drug safety alerts, product recalls, and regulatory notifications affecting various therapeutic areas. These updates are issued to ensure patient safety and maintain awareness of emerging risks or manufacturing issues.
Key Actions
- Review the full MHRA summary to identify any medicines or devices used in your setting
- Check whether any affected products are currently in stock or prescribed by your team
- Ensure relevant staff are briefed on any recalls or safety restrictions
- Follow specific guidance provided by the MHRA for each alert
Where to Find the Full Alert
The complete January 2024 letters and recalls summary is available on the MHRA website. Healthcare professionals should review this regularly to stay informed of regulatory changes and safety updates affecting their practice.
For more information and regular updates, visit first-responder.uk/news.